After a six-year absence from the RSNA technical spotlight MRIvendor Fonar is planning to return to radiology's spotlight witha family of new MRI scanners and momentum from its recent courtvictories in patent litigation with GE. In a jury trial in
After a six-year absence from the RSNA technical spotlight MRIvendor Fonar is planning to return to radiology's spotlight witha family of new MRI scanners and momentum from its recent courtvictories in patent litigation with GE.
In a jury trial in federal court earlier this year, Fonar ofMelville, NY, won a ruling that GE infringed on two patents grantedto Fonar founder Dr. Raymond Damadian. The two sides continueto wrangle over appeals to the verdict (SCAN 10/25/95).
Fonar hopes to use the jury award, along with cash from a settlementof litigation with Hitachi, to fund a comeback in the MRI industry.At the RSNA meeting, Fonar will display its Quad family, whichincludes the 0.35-tesla Quad 7000 and the 0.6-tesla Quad 12000.
Fonar will emphasize the openness of Quad 7000 and its suitabilityfor obese and claustrophobic patients. The company also plansto highlight Quad 7000's potential in delivering cost-effectiveMR mammography.
Emerging Perspectives on PSMA PET Radiotracers: An Interview with Kenneth J. Pienta, MD
April 24th 2024In a recent interview, Kenneth J. Pienta, M.D., discussed the impact of piflufolastat F18, current directions in research with other PSMA-targeted radiotracers and future possibilities for the role of PSMA PET in the imaging paradigm for prostate cancer.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.